Skip to main content
Syngene International Limited (NSE:SYNGENE)
India flag India · Delayed Price · Currency is INR
398.65
-1.05 (-0.26%)
Mar 9, 2026, 3:30 PM IST

Syngene International Revenue

Syngene International had revenue of 9.17B INR in the quarter ending December 31, 2025, a decrease of -2.82%. This brings the company's revenue in the last twelve months to 37.20B, up 5.05% year-over-year. In the fiscal year ending March 31, 2025, Syngene International had annual revenue of 36.42B with 4.41% growth.

Revenue (ttm)
37.20B
Revenue Growth
+5.05%
P/S Ratio
4.27
Revenue / Employee
5.69M
Employees
6,533
Market Cap
158.70B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202536.42B1.54B4.41%
Mar 31, 202434.89B2.96B9.26%
Mar 31, 202331.93B5.89B22.61%
Mar 31, 202226.04B4.20B19.22%
Mar 31, 202121.84B1.72B8.57%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 568.09B
Divi's Laboratories 103.14B
Apollo Hospitals Enterprise 242.15B
Cipla 279.67B
Piramal Pharma 88.71B
Eris Lifesciences 30.65B
Sagility 67.37B
NATCO Pharma 45.63B
Revenue Rankings

Syngene International News

More News